Drug intelligence / Profile preview

CRA_1802

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01

Overview

CRA_1802 is a small molecule compound belonging to the class of phenylbenzimidazoles, specifically described as 2-{5-[amino(iminium)methyl]-1H-benzimidazol-2-yl}-4-fluorobenzenolate. It has the chemical formula C14H11FN4O. The compound is referenced in structural and chemical databases but does not have an established clinical use or detailed pharmacological profile in humans. Its mechanism of action and therapeutic indications are not well characterized in public sources, though it has been studied for its interaction with drug transporters such as MATE1 (Multidrug And Toxin Extrusion protein 1)[1][2][7][9][10].

Other names
2-{5-[amino(iminium)methyl]-1H-benzimidazol-2-yl}-4-fluorobenzenolate
02

Targets

SLC47A1 (Multidrug and toxin extrusion transporter 1)

Beyond the preview

Go deeper on CRA_1802.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRA_1802.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call